Arcmed Group

Arcmed Group is a US-based, private company that emerged in 2018 from the merger of Arcmed Diba and Bio-Chem, consolidating over 120 years of combined fluidics expertise. It operates as a critical partner for OEMs, providing design, prototyping, and manufacturing of custom fluid handling components and subsystems for diagnostic and analytical instruments. The company leverages a vast configurable product platform, in-house manufacturing across five global facilities, and a strong supply chain to ensure dependable delivery and reduce development timelines for its clients. Its business model is service-oriented, supporting the entire instrument lifecycle from concept to production.

Integrated engineering and manufacturing platform for configurable fluidic subsystems, featuring a common design architecture enabling over 1 billion component combinations, rapid prototyping, in-house testing, and global production.

Arcmed competes with vertically integrated diagnostic instrument OEMs who design fluidics in-house, as well as other specialized fluidic component manufacturers and contract design firms. Its key differentiation is the combination of deep application expertise, a vast configurable product platform, and end-to-end services from design to inventory management.